Stroke Awareness: Do Your Patients Know the Signs?
New research from the American Heart and American Stroke Associations found that many Americans don't know the symptoms of stroke.
No significant difference was observed between the treatment and placebo arms in change in the Fugl-Meyer motor scores from baseline to 3-month follow-up.
The designation was granted to Revive Therapeutics, a company that specializes in cannabis-based pharmaceuticals.
For patients with ischemic stroke, infection during stroke hospitalization is associated with increased odds of 30-day readmission.